Business● Low1h ago · Nov 5, 2026, 1:04 PM
Intellia Therapeutics GAAP EPS of -$0.91 misses by $0.11, revenue of $7.16M misses by $2.61M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Intellia Therapeutics reported a GAAP EPS of -$0.91 and revenue of $7.16M, both falling short of analyst expectations. This indicates the company's financial performance for the period.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business11m agoDigital Turbine appoints new CFO; shares upSeeking Alpha TechBusiness12m agoUS labour market holds firm as weekly lay-offs tumble to 57-year lowSouth China Morning PostBusiness12m agoApple taps bond market in seven-part offeringSeeking Alpha TechBusiness14m agoTexas Pacific Land declares $0.60 dividendSeeking Alpha Tech